XBiotech Inc. (0001626878) recently filed a Form 4 with the Securities and Exchange Commission (SEC), indicating changes in the ownership of company insiders or major shareholders. Form 4 is required to be filed with the SEC whenever there are changes in ownership of company stock by directors, officers, or beneficial owners of more than 10% of the company’s stock.
XBiotech Inc. is a biopharmaceutical company focused on developing antibody therapies to treat a variety of diseases. They are known for their innovative approach to drug development, utilizing their True Human™ technology to create targeted therapies that harness the body’s natural immune response. To learn more about XBiotech Inc., you can visit their website here.
Overall, this Form 4 filing by XBiotech Inc. provides insight into the company’s ownership structure and any changes that may impact its stakeholders. Investors and analysts often monitor these filings to track insider transactions and assess the overall health and direction of the company.
Read More:
XBiotech Inc. Submits SEC Filing Form 4: Details and Significance
Leave a Reply